272BIO
Live / Registered — Registered (as of 01 Nov 2022)
What this means for you
Registered since 01 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79314153
- Registration number
- 6886491
- Mark type
- Stylized text
- Filed
- 13 Apr 2021
- Published for opposition
- 16 Aug 2022
- Registered
- 01 Nov 2022
- Attorney of record
- Robert S. Broder
Goods and services
- Class 005 — Pharmaceuticals: Veterinary preparations for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; medical preparations for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; pharmaceutical preparations for veterinary and/or medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; biological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; biotechnological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; medicines, namely, antibody therapeutic preparations and veterinary vaccines for livestock; biotherapeutic medicines for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals
- Class 040 — Treatment of materials: Custom manufacture of veterinary preparations and medical preparations; custom manufacture of pharmaceutical preparations for veterinary and medical use; custom manufacture of biological preparations for veterinary and medical use; custom manufacture of biotechnological preparations for veterinary and medical use; custom manufacture of medicines including biotherapeutic medicines
- Class 042 — Scientific and technological services: Scientific research and development; biotechnological research and development; biotechnological research and development relating to animals and livestock; biotherapeutic product development; medical and veterinary laboratory services; clinical research in the field of veterinary preparations, biotherapeutic medicines, and antibodies; conducting clinical trials for others; information, advice and consultancy relating to the aforesaid services
Owner
- 272BIO Limited, GB
- 272BIO Limited, GB
- 272BIO Limited, GB
Prosecution history
- 10 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jun 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 10 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Mar 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Feb 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Feb 2023 — FINAL DISPOSITION PROCESSED
- 01 Feb 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 23 Aug 2022 — NOTIFICATION PROCESSED BY IB
- 16 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED